Jeremy Grantham Illumina, Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$92.79 - $142.53 $16.2 Million - $24.9 Million	174,552 New	174,552 $24.3 Million
Q3 2022 Nov 10, 2022	BUY	$177.23 - $227.44 $35,446 - $45,488	200 Added 14.29%	1,600 $305,000
Q2 2022 Aug 12, 2022	BUY	$181.58 - $368.0 $254,212 - $515,200	1,400 New	1,400 $258,000
Q2 2019 Aug 13, 2019	SELL	$300.59 - $368.15 $631,239 - $773,115	-2,100 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$272.57 - $321.18 $27,257 - $32,118	100 Added 5.0%	2,100 $652,000
Q4 2018 Feb 13, 2019	BUY	$272.46 - $366.54 $544,920 - $733,080	2,000 New	2,000 $600,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.